Biological characteristics of inverted papilloma of the urinary bladder

British Journal of Urology

Volumn 77, Issue 1, 1996, Pages 55-60

  Urakami, S ^a   Igawa, M ^a   Shirakawa, H ^a   Shiina, H ^a   Ishibe, T ^a  

^a Shimime Medical University   (Japan)

Author keywords

Inverted papilloma; Malignant potential; Nuclear DNA content; p53; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE;

ARTICLE; BLADDER PAPILLOMA; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; INVERTED PAPILLOMA; PRIORITY JOURNAL;

EID: 0030033188     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.08209.x     Document Type: Article

References (24)

1. Hendcrson UVV. Allen I'VV. Bourne A]. Inverted urinary papilloma; report of 5 cases and review of the literature. Viirh Arch A Path Am 1975: 366: 177-86
2. Rasio M. Coverlizza S. Lasaponara F. Vercesi E. Giaccone G. Inverted urothelial papilloma: a lesion with malignant potential. EM Urol 1988: 14: 3 3 5-8
3. Whitesel JA. Inverted papilloma of the urinary traet: malignant potential. J Urol 1982: 127: S 39-40
4. Kunimi K. Uchibayashi T. Hasegawa T. Lee SVV. Ohkawa M. Nuclear deoxyribonucleic acid content in inverted papilloma of the urothelium. Eur Urol 1994: 26: 149-52
5. Anderstrom C. Johansson S. Petterson S. Inverted papilloma of the urinary tract. J Urol 19X2: 128: 816-8
6. Kimura G. Tsuhoi N. Nakajima H. Yoshida K. Masugi Y. Akimoto M. Inverted papilloma of the ureter with malignant transformation: a case report and review of the literature. Urol Int 1987: 42: 50-6
7. Miller C. Mohadas T. Wolf D. Prokocimer M. Rotter V. Koeffler HP. Human p53 gene localized to short arm of chromosome 17. \(ir 19S6: 319: 783-4
8. Kastan MB. Onyekwere (). Sidransky D. Vogelstein B. Craig R\V. Participation of p S3 protein in the cellular response to UNA damage. Cancer Res 1991: SI: 6304-1 1
9. Lane UP. p53. guardian of the genome, \ature 1992: 3S8: 15-6
10. Soussi T. Legros Y. Lubin R. Ory K. Schlichlholz B. Multitactorial analysis of p5 3 alteration in human cancer: a review, bit }Cancer 1994: 57: 1-9
11. Suzuki Y. Tamura G. Mutation of the p53 gene in carcinomas of the urinary system. Acta Piithol ]pn 1993: 43: 745-50
12. Lane IX Bcnchimol S. p5î oncogene or anti-oncogene? Genes Dev 1990: 4: 1-8 1
13. Bartek ). Iggo R. Gannon J. Lane DP. Genetic and immunochemical analysis of mutant p5 3 in human breast cancer cell lines. Oncoame 1990: S: 893-9
14. Böcking A. Châtelain R. Homge M. Daniel R, Gillissen A \Vohltmann D. Represemativity and reproducibility of DNA malignancy grading in different carcinomas. Acta Quant Ciitol 1989: 11: 81-6
15. 5 Blomjous CLM. Schipper NW. Baak ]PA. van Galen EM. de Voogt H]. Meyer CJLM. Retrospective study of prognostic importance of UNA flow cytometry of urinary bladder carcinoma. J Clin Piitlwl 1989: 4: 21-5
16. Tan CK. Castillo (.'. So AG. Downey KM. An auxiliary protein for DNA polymerase delta from fetal calf thymus. / Bio/ Chein 1986: 261: 12310-6
17. 7 Garcia RL. Coltrera MD. Gown A.M. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. .1m J Pathol 1991; 34: 733-9
18. Matturri L, Biondo B. Eavini P. Rocco E. Lavead AM. Nuclear DNA content as a prognostic factor in stage I transitional cell bladder carcinomas. Diuan Oncol 1993: 3: 1-4
19. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal tissues. Am }Pathol 1984; 114: 309-21
20. Watanabe R, Tomita Y. Nishiyama T, Tanikawa T, Sato S. Correlation of p53 protein expression in human urothelial transitional cell cancers with malignant potential and patient survival. Int }Urol 1994; 1: 43-8
21. Schmitz-Drager BJ. van Roeyen CRC, Grimm MO et al. p53 accumulation in precursor lesions and early stages of bladder. World] Urol 1994; 12: 79-83
22. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? -revisited! J Pathol 1994: 172: 1-4
23. Baas 10, Mulder JWR. Offerhaus GJA, Vogelstein B, Hamilton S. On evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994: 172: 5-12
24. Carder PJ. Cripps KJ, Morris R. Collins S. White S, Bird CC, Wyllie AH. Mutation of p53 gene precedes aneuploid clonal divergence in colorectal carcinoma. B J Cancer 1995: 71: 215-8